Skip to main content
. 2020 Dec 15;13(2):2089–2100. doi: 10.18632/aging.202206

Table 1. Patient characteristics according to sex.

Characteristics Male Female Total p
Number (%) 181 (41.4) 256 (58.6) 437 (100.0)
Age, mean ± SD, years 70.1 ± 8.6 69.9 ± 9.1 69.9 ± 8.9 0.802
Telomere length, mean ± SD, kbp 7.85 ± 2.06 8.40 ± 2.51 8.17 ± 2.35 0.015*
Telomere length, median (IQR), kbp 7.22 (6.54–8.24) 7.53 (6.82–9.11) 7.36 (6.70–8.60) 0.015*
Diagnosis, n (%) 0.003*
N/A 27 (14.9) 39 (15.2) 66 (15.1)
Normal 67 (37.0) 106 (41.4) 173 (39.6)
MCI 66 (36.5) 57 (22.3) 123 (28.1)
AD 21 (11.6) 54 (21.1) 75 (17.2)
Amyloid-beta PET, n (%) 0.069
N/A 36 (19.9) 76 (29.7) 112 (25.6)
Negative 91 (50.3) 113 (44.1) 204 (46.7)
Positive 54 (29.8) 67 (26.2) 121 (27.7)
Hypertension, n (%) 0.676
No 90 (49.7) 130 (50.8) 220 (50.3)
Yes 71 (39.2) 93 (36.3) 164 (37.5)
Missing 20 (11.0) 33 (12.9) 53 (12.1)
Diabetes, n (%) 0.129
No 128 (70.7) 192 (75.0) 320 (73.2)
Yes 33 (18.2) 32 (12.5) 65 (14.9)
Missing 20 (11.0) 32 (12.5) 52 (11.9)
Hyperlipidemia, n (%) 0.427
No 110 (60.8) 161 (62.9) 271 (62.0)
Yes 50 (27.6) 61 (23.8) 111 (25.4)
Missing 21 (11.6) 34 (13.3) 55 (12.6)
Heart disease, n (%) 0.499
No 142 (78.5) 203 (79.3) 345 (78.9)
Yes 19 (10.5) 21 (8.2) 40 (9.2)
Missing 20 (11.0) 32 (12.5) 52 (11.9)
Stroke, n (%) 0.452
No 152 (84.0) 216 (84.4) 368 (84.2)
Yes 9 (5.0) 8 (3.1) 17 (3.9)
Missing 20 (11.0) 32 (12.5) 52 (11.9)

SD: standard deviation; kbp: kilobase pairs; IQR: interquartile range; N/A: not available; MCI: mild cognitive impairment; AD: Alzheimer’s disease; PET: positron emission tomography. *P<0.05.